Li Tang

Title: Li Tang: Innovator in Immune Targeting Compounds

Introduction

Li Tang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, his work focuses on enhancing immune activation and targeting mechanisms.

Latest Patents

One of Li Tang's latest patents is titled "Small molecule immune agonists and immune targeting compounds and application thereof." This patent provides a series of homologous small molecule immune agonists and novel bifunctional immune targeting compounds. These compounds possess both targeting and immune activation functions, achieved by coupling small molecule immune agonists to targeting drugs. The resulting immune targeting compounds are beneficial for enhancing immune activation effects, as well as anti-tumor and other disease-fighting effects of the targeting drug. The enhanced effect is produced from a synergy of immunological anti-tumor factors, such as IFN-γ, and inhibition at pathogenic targeting sites.

Career Highlights

Li Tang has worked with notable organizations, including Shenzhen Jinyuan Huitong Trading Co., Ltd. and Shenzhen University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of immunology.

Collaborations

Li Tang has collaborated with several professionals in his field, including Guangyi Jin and Zhulin Wang. Their combined expertise has contributed to the advancement of his research and patent developments.

Conclusion

Li Tang's work in the field of immune targeting compounds showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to enhancing therapeutic strategies for combating diseases.